Table 6.
miRNA levels in plasma and plasma-derived exosomes.
| Diagnosis | Pre/Post | miR-lOb
|
miR-21
|
miR-30c
|
miR-106b
|
miR-20a
|
miR-181a
|
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P | Exo | P | Exo | P | Exo | P | Exo | P | Exo | P | Exo | ||
| Normal (N = 6) | Pre | 0.92 ± 0.21 | 1.13 ± 0.25 | 1.08 ± 0.23 | 1.04 ± 0.18 | 0.85 ± 0.23 | 0.74 ± 0.03 | 0.73 ± 0.19 | 1.09 ±0.24 | 1.25 ± 0.30 | 1.01 ± 0.15 | 1.00 ± 0.07 | 0.90 ± 0.12 |
| CP (N = 11) | Pre | 0.76 ±0.14 | 1.04 ± 0.10 | 1.01 ± 0.11 | 0.94 ±0.16 | 0.83 ± 0.18 | 0.74 ±0.11 | 1.20 ± 0.21 | 0.93 ±0.17 | 1.63 ± 0.29 | 0.95 ±0.12 | 0.80 ± 0.18 | 1.49 ± 0.27 |
| Post | 0.66 ± 0.08 | 0.95 ± 0.10 | 1.20 ± 0.21 | 0.88 ± 0.12 | 0.72 ± 0.17 | 0.78 ± 0.13 | 0.89 ± 0.11 | 0.81 ±0.12 | 1.93 ± 0.31 | 0.72 ±0.15 | 0.75 ± 0.18 | 1.65 ± 0.29 | |
| PDAC (N = 29) | Pre | 12.11 ± 1.38** | 34.76 + 6.24**† | 5.34 ± 0.66** | 7.93 ± 1.52** | 9.77 ± 1.48** | 31.71 + 7.04**† | 5.21 ± 0.62** | 4.03 ± 0.74* | 6.00 ± 0.55** | 2.59 + 0.18**† | 3.06 ± 0.34* | 8.45 + 0.88*1 |
| Post | 1.87 ±0.19## | 3.37 ± 0.47†## | 2.12 ± 0.33## | 1.61 ± 0.15## | 2.12 ± 0.27** | 2.60 ± 0.31## | 1.56 ± 0.21## | 1.28 ±0.09## | 2.00 ± 0.21## | 1.28 ± 0.10†## | 2.65 ± 0.32 | 5.65 ± 0.60†#+ | |
| Diagnosis | Pre/Post | miR-483
|
miR-let7a
|
miR-122
|
|||
| P | Exo | P | Exo | P | Exo | ||
| Normal (N = 6) | Pre | 1.27 ± 0.14 | 1.21 ± 0.15 | 1.01 ± 0.04 | 0.97 ± 0.06 | 1.08 ± 0.19 | 1.00 ± 0.08 |
| CP (N = 11) | Pre | 1.33 ± 0.20 | 1.40 ± 0.43 | 1.66 ± 0.25 | 1.60 ± 0.26 | 1.21 ± 0.25 | 1.47 ± 0.34 |
| Post | 1.45 ± 0.25 | 1.25 ± 0.26 | 1.46 ± 0.15 | 1.60 ± 0.18† | 1.51 ± 0.38 | 1.21 ± 0.11 | |
| PDAC (N = 29) | Pre | 2.23 ± 0.32 | 1.77 ± 0.31 | 0.56 ± 0.04** | 0.40 ± 0.03**† | 0.52 ± 0.04** | 0.39 ± 0.04**† |
| Post | 2.07 ± 0.23 | 2.27 ± 0.34 | 1.48 ± 0.09## | 1.70 ± 0.12## | 3.93 ± 0.57** | 1.77 ± 0.10†##+ | |
Data are based on assays using plasma (P) or exosomes (Exo) from 6 normal controls, 11 chronic pancreatitis (CP) patients, and 29 patients with pancreatic ductal adenocarcinoma (PDAC). Data were analyzed by ANOVA followed by Bonferroni adjustment.
p < 0.01, and
p < 0.001 by comparison with corresponding values in normal or CP plasma or exosomes;
p < 0.02 by comparison with corresponding values in plasma;
p < 0.05 and
p < 0.01 by comparison with corresponding pre-resection values;
p < 0.01 and by comparison with corresponding values in normal controls.